The focus of this GEN Market & Tech Analysis Report is to present some characteristics of selected Northern/Central EU markets vis-à-vis institutions, funding/opportunities in the broader stem cells field [and focusing as appropriate on stem cell banking, iPSCs, cord blood]. We present here data collected by our U.K. research team via primary market research from across Europe focusing on the following countries:

U.K.
Germany
The Netherlands
Belgium
Sweden

Taken together, these data frame some of the characteristics, institutions as well as stem cell research opportunities in these countries. In a future GENReport, we will provide an analysis of the regulatory landscape in selected EU countries.

Enal Razvi, Ph.D., conducted his doctoral work on viral immunology and subsequent to receiving his Ph.D. went on to the Rockefeller University in New York to serve as Aaron Diamond Post-doctoral fellow under Professor Ralph Steinman [Nobel Prize Winner in 2011 for his discovery of dendritic cells in the early-70s with Zanvil Cohn]. Subsequently, Dr. Razvi completed his research fellowship at Harvard Medical School. For the last two decades Dr. Razvi has worked with small and large companies and consulted for more than 100 clients worldwide. He currently serves as Biotechnology Analyst and Managing Director of SelectBio U.S. He can be reached at enal@selectbio.us.

To enjoy more articles like this from GEN, click here to subscribe now!

Stem Cells in the EU: Northern and Central Markets

Learn about stem cell institutions and opportunities in the U.K., Germany, the Netherlands, Belgium, and Sweden in this incisive report.